Related Experiment Video
Updated: Jun 14, 2025
Fabrication of Decellularized Cartilage-derived Matrix Scaffolds
Published on: January 7, 2019
Drug-Loaded Bioscaffolds for Osteochondral Regeneration
Yifan Tong1, Jiaqi Yuan1, Zhenguang Li1
1Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-like Intelligence, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai 200434, China.
Drug-loaded 3D-printed bioscaffolds show promise for treating osteochondral defects by combining physical stimulation with drug therapy. This approach enhances tissue regeneration for hyaline cartilage and subchondral bone repair.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Tissue Engineering
Background:
- Osteochondral defects involve complex tissue loss affecting hyaline cartilage and subchondral bone.
- Current clinical treatments for osteochondral defects have limitations in achieving desired regenerative outcomes.
- Three-dimensional (3D) printing offers precise control over bioscaffold structures for osteochondral defect repair.
Purpose of the Study:
- To review the physiological characteristics of osteochondral tissue and current treatment modalities.
- To discuss the latest advancements in drug-loaded 3D-printed bioscaffolds for osteochondral regeneration.
- To provide perspectives on scaffold design, drug release control, and biosafety for clinical translation.
Main Methods:
- Review of existing literature on osteochondral defects and tissue engineering strategies.
- Analysis of the classification, characteristics, and applications of drug-loaded 3D bioscaffolds.
- Discussion of future directions in scaffold design and drug delivery systems.
Main Results:
- 3D-printed bioscaffolds provide a suitable microenvironment for cell growth and nutrient transport.
- Drug-loaded bioscaffolds enhance osteochondral repair through synergistic physical and therapeutic stimulation.
- Significant progress has been made in developing advanced drug-loaded bioscaffolds.
Conclusions:
- Drug-loaded 3D bioscaffolds represent a promising therapeutic strategy for osteochondral defects.
- Further research into scaffold design, controlled drug release, and biosafety is crucial for clinical application.
- This review serves as a reference for developing novel bioscaffolds for osteochondral regeneration.
